CNTX - Centrexion Therapeutics Corporation

NasdaqGS . Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/2016
Total Revenue--
Cost of Revenue--
Gross Profit--
Operating Expenses
Research Development17,62227,788
Selling General and Administrative6,4335,443
Non Recurring--
Others--
Total Operating Expenses24,05533,231
Operating Income or Loss-24,055-33,231
Income from Continuing Operations
Total Other Income/Expenses Net-1,000-4,441
Earnings Before Interest and Taxes-24,055-33,231
Interest Expense-983-2,126
Income Before Tax-25,055-37,672
Income Tax Expense-441-
Minority Interest--
Net Income From Continuing Ops-24,614-37,672
Non-recurring Events
Discontinued Operations--
Extraordinary Items--
Effect Of Accounting Changes--
Other Items--
Net Income
Net Income-24,614-37,672
Preferred Stock And Other Adjustments--
Net Income Applicable To Common Shares-24,742-37,672